Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from LDHC in lung adenocarcinoma

BackgroundLactate dehydrogenase C (LDHC) is a kind of cancer-testis antigen (CTA) that has been reported to be a biomarker for diagnosis, efficacy evaluation, and recurrence monitoring of lung adenocarcinoma (LUAD). This study aims to assess the value of LDHC in peptide-based vaccines for LUAD immun...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ruifang Zhong, Xiaohong Guo, Chuncai Wu, Yangyi Guo, Yanli Kang, Jianbin You, Falin Chen, Qianshun Chen, Liangyuan Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-04-01
coleção:	Frontiers in Immunology
Assuntos:	lung adenocarcinoma HLA-A2 lactate dehydrogenase C recombinant protein peptides
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1564731/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!